Clinical trials
Recruiting Breast Neoplasms trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
92 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 2 |
| 2014 | 2 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 4 |
| 2021 | 2 |
| 2022 | 10 |
| 2023 | 14 |
| 2024 | 15 |
| 2025 | 26 |
| 2026 | 11 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 92 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hoffmann-La Roche | 7 |
| Novartis Pharmaceuticals | 6 |
| AstraZeneca | 5 |
| Eli Lilly and Company | 5 |
| German Cancer Research Center | 4 |
| Women's Cancer Study Group GmbH | 4 |
| Merck Sharp & Dohme LLC | 3 |
| Prof. Wolfgang Janni | 3 |
| University Hospital Tuebingen | 3 |
| European Breast Cancer Research Association of Surgical Trialists | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 92 |
| Colorectal Neoplasms | 11 |
| Neoplasm Metastasis | 10 |
| Prostatic Neoplasms | 9 |
| Ovarian Neoplasms | 8 |
| Neoplasms | 7 |
| Head and Neck Neoplasms | 6 |
| Lung Neoplasms | 6 |
| Triple Negative Breast Neoplasms | 6 |
| Esophageal Neoplasms | 5 |
Trials
Showing 1 to 25 of 92. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.